Effect of Alogliptin Combined with Pioglitazone on β-Cell Function and Insulin Resistance in Metformin-Treated Patients with Type 2 Diabetes

被引：0
|
作者：
Defronzo, Ralph A.
Burant, Charles F.
Fleck, Penny
Wilson, Craig
Mekki, Qais
Pratley, Richard
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [31] Effects of pioglitazone and linagliptin on glycemic control, lipid profile and hs-CRP in metformin-treated patients with type 2 diabetes: a comparative study
    Zamani, Batool
    Tabatabizadeh, Seyyed Mashaalah
    Gilasi, Hamidreza
    Yazdani, Shadi
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2024, 44 (04) : 385 - 391
  • [32] Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS
    Jensterle, Mojca
    Goricar, Katja
    Janez, Andrej
    ENDOCRINE RESEARCH, 2017, 42 (04) : 261 - 268
  • [33] Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration
    S. Larsen
    R. Rabøl
    C. N. Hansen
    S. Madsbad
    J. W. Helge
    F. Dela
    Diabetologia, 2012, 55 : 443 - 449
  • [34] Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration
    Larsen, S.
    Rabol, R.
    Hansen, C. N.
    Madsbad, S.
    Helge, J. W.
    Dela, F.
    DIABETOLOGIA, 2012, 55 (02) : 443 - 449
  • [35] Addition of Alogliptin vs Uptitration of Pioglitazone Dose in Type 2 Diabetes Mellitus (T2DM) Patients on Metformin Plus Pioglitazone Therapy
    Bosi, Emanuele
    Ellis, Graham
    Moneuse, Patrick
    Wilson, Craig
    Fleck, Penny
    DIABETES, 2010, 59 : A148 - A148
  • [36] Effect of hydroxychloroquine on beta cell function, insulin resistance, and inflammatory markers in type 2 diabetes patients uncontrolled on glimepiride and metformin therapy
    Rajput, Rajesh
    Upadhyay, Parankush
    Rajput, Siddhant
    Saini, Suyasha
    Kharab, Simmi
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (06) : 955 - 960
  • [37] Effect of hydroxychloroquine on beta cell function, insulin resistance, and inflammatory markers in type 2 diabetes patients uncontrolled on glimepiride and metformin therapy
    Rajesh Rajput
    Parankush Upadhyay
    Siddhant Rajput
    Suyasha Saini
    Simmi Kharab
    International Journal of Diabetes in Developing Countries, 2023, 43 : 955 - 960
  • [38] Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
    Dziegielewska-Gesiak, Sylwia
    Fatyga, Edyta
    Pilot, Magdalena
    Wierzgon, Aleksander
    Muc-Wierzgon, Malgorzata
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 3589 - 3599
  • [39] Combined metformin and insulin therapy for patients with type 2 diabetes mellitus
    Ponssen, HH
    Elte, JWF
    Lehert, P
    Schouten, JP
    Bets, D
    CLINICAL THERAPEUTICS, 2000, 22 (06) : 709 - 718
  • [40] Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year
    Ahrén, B
    Pacini, G
    Foley, JE
    Schweizer, A
    DIABETES CARE, 2005, 28 (08) : 1936 - 1940
12345